Compare CSPI & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CSPI | NRXS |
|---|---|---|
| Founded | 1968 | 2011 |
| Country | United States | United States |
| Employees | 123 | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5M | 78.9M |
| IPO Year | 1994 | 2023 |
| Metric | CSPI | NRXS |
|---|---|---|
| Price | $9.75 | $7.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 9.9K | ★ 177.3K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.15% | N/A |
| EPS Growth | ★ 75.00 | 22.13 |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $58,730,000.00 | $3,569,282.00 |
| Revenue This Year | N/A | $172.91 |
| Revenue Next Year | N/A | $115.71 |
| P/E Ratio | $233.13 | ★ N/A |
| Revenue Growth | 6.36 | ★ 32.89 |
| 52 Week Low | $7.55 | $2.20 |
| 52 Week High | $15.49 | $9.33 |
| Indicator | CSPI | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 44.43 |
| Support Level | $9.72 | $6.80 |
| Resistance Level | $10.59 | $8.03 |
| Average True Range (ATR) | 0.58 | 0.63 |
| MACD | 0.00 | -0.16 |
| Stochastic Oscillator | 65.32 | 8.97 |
CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).